ASPI - NASDAQ
ASP Isotopes Inc. Common Stock
$7.55
+5.6%ASP Isotopes Inc., a pre-commercial stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It develops Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company also Uranium-235, an isotope of uranium for carbon-free energy industry. ASP Isotopes Inc. was incorporated in 2021 and is based in Boca Raton, Florida.
At a Glance
Live Snapshotaspi
Total Current Liabilities
Last Annual Value
32.70M
3-Year CAGR
157%
5-Year CAGR
155%
10-Year CAGR
60%
ASP Isotopes Inc. Common Stock Competitors Analysis of Total Current Liabilities
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
ASP Isotopes Inc. Common Stock NASDAQ:ASPI | 32.70M | 79.3% | 155.0% | N/A | |
 Tronox Holdings plc NYSE:TROX | 919.00M | 6.9% | 2.3% | 5.0% | |
 Westlake Chemical Partners LP NYSE:WLKP | 51.30M | -3.1% | -13.6% | 3.1% | |
 Oil-Dri Corporation of America NYSE:ODC | 69.19M | 5.6% | 12.2% | 8.5% | |
 i-80 Gold Corp. AMEX:IAUX | 138.26M | 28.5% | 35.8% | N/A | |
 Green Plains Inc. NASDAQ:GPRE | 268.71M | -11.3% | -10.6% | -7.6% | |
265.60M | -1.1% | 6.3% | -3.0% | ||
 Stepan Company NYSE:SCL | 666.49M | 3.1% | 5.9% | 8.4% | |
 United States Antimony Corporation NYSE:UAMY | 10.18M | 124.7% | 37.5% | 11.6% |
ASP Isotopes Inc. Common Stock Fair Value Envelope
Related Guides
Continue your ASPI research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.